Explore "pompedisease" with insightful episodes like "Rituximab for MS, food security and cognition, in utero treatment for Pompe disease" and "MPR Weekly Dose 89 - COVID Vaccine Booster Dose; Vaccines Recommended in Pregnancy; Post-Vaccine Myocarditis Study; Moderna Efficacy at 6 Months; Pompe Disease Tx; FDA Denies Roxadustat" from podcasts like ""Neurology Today in 5" and "MPR Weekly Dose"" and more!
In this week’s podcast, Neurology Today’s editor-in-chief discusses why MS specialists advocate for rituximab for MS, how food security may relate to cognition, and a novel in utero therapy for Pompe diseasea.
Big news on the COVID-19 vaccine booster dose. The CDC issues new recommendations on vaccines. What protection the Moderna vaccine offers after 6 months. A treatment approved for Pompe disease. And the FDA denies an application for a new roxadustat indication.
Stay up to date
For any inquiries, please email us at hello@podcastworld.io